26 May Craig Gibbs, Ph.D., M.B.A.
Dr. Gibbs worked for Gilead Sciences for nearly three decades in a variety of leadership positions spanning research, corporate development, and most recently, Vice President of Commercial Strategy/Commercial Planning and Operations. His broad expertise contributed to the development and commercial launch of 12 FDA-approved drugs. He currently serves on the Board of Tobira Therapeutics and is an advisor to several biotechnology companies and venture capital firms. Prior to Gilead, Dr. Gibbs served as a Scientist in the Department of Protein Engineering at Genentech. Dr. Gibbs earned his Ph.D. in molecular biology from the University of Glasgow in Scotland and his M.B.A from Golden Gate University in San Francisco.